List of Tables
Table 1. Global Nucleic Acids for Molecular Diagnosis Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of DNA Series
Table 3. Key Players of RNA Series
Table 4. Global Nucleic Acids for Molecular Diagnosis Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Nucleic Acids for Molecular Diagnosis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Nucleic Acids for Molecular Diagnosis Market Size by Region (US$ Million), 2021–2026
Table 7. Global Nucleic Acids for Molecular Diagnosis Market Share by Region (2021–2026)
Table 8. Global Nucleic Acids for Molecular Diagnosis Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Nucleic Acids for Molecular Diagnosis Market Share by Region (2027–2032)
Table 10. Nucleic Acids for Molecular Diagnosis Market Trends
Table 11. Nucleic Acids for Molecular Diagnosis Market Drivers
Table 12. Nucleic Acids for Molecular Diagnosis Market Challenges
Table 13. Nucleic Acids for Molecular Diagnosis Market Restraints
Table 14. Global Nucleic Acids for Molecular Diagnosis Revenue by Players (US$ Million), 2021–2026
Table 15. Global Nucleic Acids for Molecular Diagnosis Market Share by Players (2021–2026)
Table 16. Global Top Nucleic Acids for Molecular Diagnosis Players by Tier (Tier 1, Tier 2, and Tier 3), based on Nucleic Acids for Molecular Diagnosis Revenue, 2025
Table 17. Ranking of Global Top Nucleic Acids for Molecular Diagnosis Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Nucleic Acids for Molecular Diagnosis Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Nucleic Acids for Molecular Diagnosis, Headquarters and Area Served
Table 20. Global Key Players of Nucleic Acids for Molecular Diagnosis, Products and Applications
Table 21. Global Key Players of Nucleic Acids for Molecular Diagnosis, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Nucleic Acids for Molecular Diagnosis Market Size by Type (US$ Million), 2021–2026
Table 24. Global Nucleic Acids for Molecular Diagnosis Revenue Market Share by Type (2021–2026)
Table 25. Global Nucleic Acids for Molecular Diagnosis Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Nucleic Acids for Molecular Diagnosis Revenue Market Share by Type (2027–2032)
Table 27. Global Nucleic Acids for Molecular Diagnosis Market Size by Application (US$ Million), 2021–2026
Table 28. Global Nucleic Acids for Molecular Diagnosis Revenue Market Share by Application (2021–2026)
Table 29. Global Nucleic Acids for Molecular Diagnosis Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Nucleic Acids for Molecular Diagnosis Revenue Market Share by Application (2027–2032)
Table 31. North America Nucleic Acids for Molecular Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Nucleic Acids for Molecular Diagnosis Market Size by Country (US$ Million), 2021–2026
Table 33. North America Nucleic Acids for Molecular Diagnosis Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Nucleic Acids for Molecular Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Nucleic Acids for Molecular Diagnosis Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Nucleic Acids for Molecular Diagnosis Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Nucleic Acids for Molecular Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Nucleic Acids for Molecular Diagnosis Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Nucleic Acids for Molecular Diagnosis Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Country (US$ Million), 2027–2032
Table 46. Danaher Corporation Company Details
Table 47. Danaher Corporation Business Overview
Table 48. Danaher Corporation Nucleic Acids for Molecular Diagnosis Product
Table 49. Danaher Corporation Revenue in Nucleic Acids for Molecular Diagnosis Business (US$ Million), 2021–2026
Table 50. Danaher Corporation Recent Development
Table 51. Merck KGaA Company Details
Table 52. Merck KGaA Business Overview
Table 53. Merck KGaA Nucleic Acids for Molecular Diagnosis Product
Table 54. Merck KGaA Revenue in Nucleic Acids for Molecular Diagnosis Business (US$ Million), 2021–2026
Table 55. Merck KGaA Recent Development
Table 56. Eurofins Scientific SE Company Details
Table 57. Eurofins Scientific SE Business Overview
Table 58. Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Product
Table 59. Eurofins Scientific SE Revenue in Nucleic Acids for Molecular Diagnosis Business (US$ Million), 2021–2026
Table 60. Eurofins Scientific SE Recent Development
Table 61. Thermo Fisher Scientific Inc. Company Details
Table 62. Thermo Fisher Scientific Inc. Business Overview
Table 63. Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Product
Table 64. Thermo Fisher Scientific Inc. Revenue in Nucleic Acids for Molecular Diagnosis Business (US$ Million), 2021–2026
Table 65. Thermo Fisher Scientific Inc. Recent Development
Table 66. Agilent Technologies, Inc. Company Details
Table 67. Agilent Technologies, Inc. Business Overview
Table 68. Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Product
Table 69. Agilent Technologies, Inc. Revenue in Nucleic Acids for Molecular Diagnosis Business (US$ Million), 2021–2026
Table 70. Agilent Technologies, Inc. Recent Development
Table 71. Kaneka Eurogentec S.A. Company Details
Table 72. Kaneka Eurogentec S.A. Business Overview
Table 73. Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Product
Table 74. Kaneka Eurogentec S.A. Revenue in Nucleic Acids for Molecular Diagnosis Business (US$ Million), 2021–2026
Table 75. Kaneka Eurogentec S.A. Recent Development
Table 76. Aji Bio-Pharma Company Details
Table 77. Aji Bio-Pharma Business Overview
Table 78. Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Product
Table 79. Aji Bio-Pharma Revenue in Nucleic Acids for Molecular Diagnosis Business (US$ Million), 2021–2026
Table 80. Aji Bio-Pharma Recent Development
Table 81. L.G.C Biosearch Technologies Company Details
Table 82. L.G.C Biosearch Technologies Business Overview
Table 83. L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Product
Table 84. L.G.C Biosearch Technologies Revenue in Nucleic Acids for Molecular Diagnosis Business (US$ Million), 2021–2026
Table 85. L.G.C Biosearch Technologies Recent Development
Table 86. Integrated DNA Technologies Company Details
Table 87. Integrated DNA Technologies Business Overview
Table 88. Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Product
Table 89. Integrated DNA Technologies Revenue in Nucleic Acids for Molecular Diagnosis Business (US$ Million), 2021–2026
Table 90. Integrated DNA Technologies Recent Development
Table 91. Bio-synthesis Inc. Company Details
Table 92. Bio-synthesis Inc. Business Overview
Table 93. Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Product
Table 94. Bio-synthesis Inc. Revenue in Nucleic Acids for Molecular Diagnosis Business (US$ Million), 2021–2026
Table 95. Bio-synthesis Inc. Recent Development
Table 96. metabion Company Details
Table 97. metabion Business Overview
Table 98. metabion Nucleic Acids for Molecular Diagnosis Product
Table 99. metabion Revenue in Nucleic Acids for Molecular Diagnosis Business (US$ Million), 2021–2026
Table 100. metabion Recent Development
Table 101. QIAGEN Company Details
Table 102. QIAGEN Business Overview
Table 103. QIAGEN Nucleic Acids for Molecular Diagnosis Product
Table 104. QIAGEN Revenue in Nucleic Acids for Molecular Diagnosis Business (US$ Million), 2021–2026
Table 105. QIAGEN Recent Development
Table 106. Hongene Company Details
Table 107. Hongene Business Overview
Table 108. Hongene Nucleic Acids for Molecular Diagnosis Product
Table 109. Hongene Revenue in Nucleic Acids for Molecular Diagnosis Business (US$ Million), 2021–2026
Table 110. Hongene Recent Development
Table 111. Synthgene Company Details
Table 112. Synthgene Business Overview
Table 113. Synthgene Nucleic Acids for Molecular Diagnosis Product
Table 114. Synthgene Revenue in Nucleic Acids for Molecular Diagnosis Business (US$ Million), 2021–2026
Table 115. Synthgene Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Nucleic Acids for Molecular Diagnosis Picture
Figure 2. Global Nucleic Acids for Molecular Diagnosis Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Nucleic Acids for Molecular Diagnosis Market Share by Type: 2025 vs 2032
Figure 4. DNA Series Features
Figure 5. RNA Series Features
Figure 6. Global Nucleic Acids for Molecular Diagnosis Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Nucleic Acids for Molecular Diagnosis Market Share by Application: 2025 vs 2032
Figure 8. Infectious Diseases Case Studies
Figure 9. Early Cancer Screening Case Studies
Figure 10. Blood Screening Case Studies
Figure 11. Genetic Diseases Case Studies
Figure 12. Genome Sequencing Case Studies
Figure 13. Other Case Studies
Figure 14. Nucleic Acids for Molecular Diagnosis Report Years Considered
Figure 15. Global Nucleic Acids for Molecular Diagnosis Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 16. Global Nucleic Acids for Molecular Diagnosis Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Nucleic Acids for Molecular Diagnosis Market Share by Region: 2025 vs 2032
Figure 18. Global Nucleic Acids for Molecular Diagnosis Market Share by Players in 2025
Figure 19. Global Nucleic Acids for Molecular Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Nucleic Acids for Molecular Diagnosis Revenue in 2025
Figure 21. North America Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. North America Nucleic Acids for Molecular Diagnosis Market Share by Country (2021–2032)
Figure 23. United States Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Canada Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Nucleic Acids for Molecular Diagnosis Market Share by Country (2021–2032)
Figure 27. Germany Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. France Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. U.K. Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Italy Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Russia Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Ireland Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Nucleic Acids for Molecular Diagnosis Market Share by Region (2021–2032)
Figure 35. China Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Japan Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. South Korea Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Southeast Asia Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. India Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Australia & New Zealand Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Nucleic Acids for Molecular Diagnosis Market Share by Country (2021–2032)
Figure 43. Mexico Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Brazil Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Share by Country (2021–2032)
Figure 47. Israel Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Saudi Arabia Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UAE Nucleic Acids for Molecular Diagnosis Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Danaher Corporation Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021–2026)
Figure 51. Merck KGaA Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021–2026)
Figure 52. Eurofins Scientific SE Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021–2026)
Figure 53. Thermo Fisher Scientific Inc. Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021–2026)
Figure 54. Agilent Technologies, Inc. Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021–2026)
Figure 55. Kaneka Eurogentec S.A. Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021–2026)
Figure 56. Aji Bio-Pharma Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021–2026)
Figure 57. L.G.C Biosearch Technologies Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021–2026)
Figure 58. Integrated DNA Technologies Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021–2026)
Figure 59. Bio-synthesis Inc. Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021–2026)
Figure 60. metabion Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021–2026)
Figure 61. QIAGEN Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021–2026)
Figure 62. Hongene Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021–2026)
Figure 63. Synthgene Revenue Growth Rate in Nucleic Acids for Molecular Diagnosis Business (2021–2026)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
